Filed Pursuant to Rule 433
Registration Statement No. 333-132051
CSX Corporation
Final pricing terms as of September 15, 2006
$400,000,000 6.000% Notes due October 1, 2036
| Issuer |
CSX Corporation | |
| Issue Format |
SEC Registered | |
| Security |
Notes | |
| Ratings |
Baa2/BBB (stable/stable) (Moody’s/S&P) | |
| Principal Amount |
$400,000,000 | |
| Pricing Date |
September 15, 2006 | |
| Settlement Date |
September 20, 2006 | |
| Maturity Date |
October 1, 2036 | |
| Coupon Pay Dates |
Each October 1 & April 1 | |
| First Coupon |
April 1, 2007 | |
| Day Count Convention |
30/360 | |
| Denominations |
$2,000 or integral multiples of $1,000 in excess thereof | |
| Make Whole Provision |
T+ 20 bps | |
| Benchmark Treasury |
T 4.500 due 02/36 | |
| Benchmark Treasury Yield |
4.911% | |
| Benchmark Treasury Price |
$93-20+ | |
| Reoffer Spread to Treasury |
+ 112 bps | |
| Reoffer Yield |
6.031% | |
| Coupon |
6.000% | |
| Reoffer Price to Public |
99.569% | |
| CUSIP |
126408GH0 | |
| ISIN |
US126408GH06 | |
| Joint Book-Running Managers |
Credit Suisse Securities (USA) LLC UBS Securities LLC | |
| Co-Managers: |
Barclays Capital Inc. Citigroup Global Markets Inc. Deutsche Bank Securities Inc. J.P. Morgan Securities Inc. Mitsubishi UFJ Securities International plc Morgan Stanley & Co. Incorporated Scotia Capital (USA) Inc. | |
| Use of Proceeds |
Repay borrowings; general corporate purposes | |
The issuer has filed a registration statement (including a prospectus) with the Securities and Exchange Commission (the “SEC”) for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC website at www.sec.gov <http://www.sec.gov>. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus, any prospectus supplement or free writing prospectus for this offering if you request it by calling toll free UBS Securities LLC at 1-888-722-9555 ext 1088 or Credit Suisse Securities (USA) LLC at 1-800-221-1037, or through your usual contact at UBS Securities LLC or Credit Suisse Securities (USA) LLC.